Cathie Wood's ARK ETFs have made their daily trades for Thursday, December 26th, 2024, with significant activity across a range of tech and biotech stocks. Leading the day's trades was a substantial purchase of GitLab Inc (NASDAQ:GTLB) shares, with ARK's flagship ARKK ETF adding 219,606 shares valued at approximately $13.3 million. This move underscores ARK's continued confidence in the DevOps platform provider, following a pattern of accumulation over recent days, including a purchase of nearly 270,000 shares just two days prior.
In contrast, ARK took a step back from Palantir Technologies Inc (NYSE:NASDAQ:PLTR), selling 103,410 shares worth about $8.5 million. This sale marks a continuation of ARK's sell-off in the data analytics firm, having reduced its position by over 42,000 shares on December 24th and by over 22,000 shares on December 23rd.
Another notable transaction was ARK's sale of 15,342 shares of Block Inc (NYSE:SQ), the payment solutions company formerly known as Square, totaling roughly $1.4 million. This sell-off comes on the heels of ARK divesting over 23,000 shares of Block on December 24th.
ARK also bolstered its investment in CRISPR Therapeutics AG (NASDAQ:CRSP), a company at the forefront of gene-editing technology, buying 57,889 shares with a total dollar value of approximately $2.4 million. This follows a recent trend of ARK increasing its stake in CRISPR, as evidenced by the purchase of over 35,000 shares on December 24th.
In the biotech space, ARK's trades included a smaller purchase of 10X Genomics Inc (NASDAQ:TXG), acquiring a combined 9,256 shares across its ARKK and ARKG ETFs, valued at around $136,000. Meanwhile, ARK continued to pare down its holdings in Adaptive Biotechnologies Corp (NASDAQ:ADPT) and Veracyte Inc (NASDAQ:VCYT), selling 75,957 and 741 shares, respectively.
Investors following ARK's movements will note the trend of selective trimming and targeted buying, as Cathie Wood's ETFs navigate the market with a focus on innovative companies poised for growth. Each trade reflects ARK's strategic adjustments, balancing between sectors and individual stock prospects.
Finding the best broker is a critical step in maximizing your trading success. With so many options to choose from, itβs important to select a broker that aligns with your goals. Discover why SmileTradeFX is a preferred choice for traders across the globe.
SmileTradeFX combines cutting-edge technology with top-tier support to create a trading environment that suits both new and experienced traders. Offering a wide range of assets, competitive spreads, and advanced tools, SmileTradeFX empowers you to trade with confidence and efficiency.
Choosing SmileTradeFX means choosing reliability, innovation, and performance. From secure platforms to educational resources, this broker provides everything you need to stay ahead in the fast-paced world of trading. Experience the difference with SmileTradeFX and take your trading to new heights
Β©οΈSmiletradefx.com β Licensed under SERC Cambodia.
ππ«πππ π°π’ππ‘ π π¬π¦π’π₯π
π§βπΌ Business Support: https://t.me/sm.business.support
π¨βπ§ Technical Support: https://t.me/sm.technical.support
π± Liquidity Support: https://t.me/sm.liquidity.support
Β
Β
LONDON (Reuters) - British Prime Minister Keir Starmer has asked the country's regulators, including the financial and competition watchdogs, to remove barriers to growth in an effort to revive a sluggish economy, Sky News reported on Saturday.
BRASILIA (Reuters) -Brazil has stopped issuing temporary work visas for BYD (SZ:002594), the Ministry of Foreign Affairs said on Friday, in the wake of accusations that some workers at a site owned by the Chinese electric vehicle producer had been victims of human trafficking.
WASHINGTON (Reuters) -President-elect Donald Trump has urged the U.S. Supreme Court to pause implementation of a law that would ban popular social media app TikTok or force its sale, arguing he should have time after taking office to pursue a "political resolution" to the issue.
